A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e318226b5fa
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Elsevier BV